by Eric Christianson | Jun 25, 2025 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
When comparing venlafaxine versus desvenlafaxine, we must first recognize that they are both part of the drug class called SNRIs. Both of these medications work by inhibiting the reuptake of both serotonin and norepinephrine. Venlafaxine comes in an extended-release...
by Eric Christianson | Jun 22, 2025 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Nonsteroidal anti-inflammatory drugs (NSAIDs) are routinely used for pain and inflammation, but they are also commonly implicated in clinically significant interactions. As medication experts, pharmacists play a critical role in recognizing and navigating these risks....
by Eric Christianson | Jun 18, 2025 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Rheumatoid arthritis (RA) often requires complex, long-term medication regimens. This polypharmacy increases the risk of clinically significant drug interactions that can impact efficacy and safety. Below are five of the most important drug interactions encountered in...
by Eric Christianson | Jun 15, 2025 | Endocrine Case Studies
One of my biggest pet peeves is the use of sulfonylureas with insulin. Recall that sulfonylureas stimulate the release of insulin and in many patients with Type 2 diabetes we may not be getting much out of the sulfonylurea or in some cases, the extra boost in insulin...
by Eric Christianson | Jun 11, 2025 | Drug Interaction Case Studies and Education For Pharmacists
Trimethoprim-sulfamethoxazole (Bactrim) is a commonly prescribed antibiotic for urinary tract and other infections. However, it’s also associated with several clinically significant drug interactions that can lead to serious patient harm if overlooked. Here are my top...
